The increase in the expression of GPX4 and SLC7A11, along with the reduction of iron accumulation via upregulation of Prdx6, allows for a reduction in in vitro damage to podocytes in a model of DKD (65). Here, SLC7A11 is linked to diabetic kidney disease.